Nexstim initiated with a BUY rating by NuWays AG
Original-research coverage from NuWays AG rates Nexstim as BUY, per a TradingView News dissemination.
Original-Research: Nexstim - from NuWays AG02.09.2026 / 09:00 CET/CESTDissemination of a Research, transmitted by EQS News - a service of EQS Group.The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice or an invitation t…